Community Pharmacists' Preparedness for Substituting Biologics and Dispensing Biosimilars: Lessons Learned From a Multinational Survey

Tiivistelmä

Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.

Lue koko artikkeli (sciencedirect.com)

Tekijät

Isabelle Arnet, Melina Verbeek, Anna Birna Almarsdóttir, Liese Barbier, Rhonda Clifford, Christiane Eickhoff, Kurt Hersberger, Isabelle Huys, Kenny Lee, Kritsanee Saramunee, Martin Schulz, David Zgarrick, Kati Sarnola 

Lisätietoja julkaisusta

• Vertaisarvioitu: kyllä.
• Avoin saatavuus: kyllä.
• Koko viite: Arnet, I., Verbeek, M., Almarsdóttir Anna, B., Barbier, L., Clifford, R., Eickhoff, C., Hersberger, K., Huys, I., Lee, K., Saramunee, K., Schulz, M., Zgarrick, D., & Sarnola, K. (2021). Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational survey. Exploratory research in clinical and social pharmacy, 4, 100084. https://doi.org/10.1016/j.rcsop.2021.100084